1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INOZYME PHARMA INC
Inozyme Pharma Inc XNAS: INZY

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Inozyme Pharma Inc is on 06 Aug 2025 for the purpose of Inozyme Pharma Inc Second Quarter Earnings Results for 2025 See details


Insider Trading disclosures for Inozyme Pharma Inc

The latest disclosure was made by Douglas A. Treco in Inozyme Pharma Inc where a trade of 2,815 Common Stock done at an average price of $0.7 was reported to US exchanges on June 25, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Douglas A. Treco Director, CEO & Chairman Grant, award, or other acquisition of securities at price $ 0.74 per share. 25 Jun 2025 2,815 43,861 - 0.7 2,083 Common Stock
Sanjay Subramanian SVP, CFO & Head of BD Grant, award, or other acquisition of securities at price $ 0.74 per share. 25 Jun 2025 6,813 39,701 - 0.7 5,042 Common Stock
Matthew Winton COO Grant, award, or other acquisition of securities at price $ 0.74 per share. 25 Jun 2025 14,355 21,743 - 0.7 10,623 Common Stock
Axel Bolte Director 15 May 2025 152,823 419,519 - 1.0 149,767 Common Stock
Axel Bolte Director 15 May 2025 4,407 0 - - Stock Option (right to buy)
Axel Bolte Director 15 May 2025 152,823 0 - - Stock Option (right to buy)
Axel Bolte Director 15 May 2025 4,407 423,926 - 1.0 4,319 Common Stock
Douglas A. Treco Director, CEO & Chairman 01 Apr 2025 25,000 50,000 - - Restricted Stock Units
Douglas A. Treco Director, CEO & Chairman 01 Apr 2025 8,819 41,046 - 0.9 7,849 Common Stock
Douglas A. Treco Director, CEO & Chairman 01 Apr 2025 25,000 49,865 - - Common Stock
Sanjay Subramanian SVP, CFO & Head of BD Grant, award, or other acquisition of securities at price $ 0.77 per share. 31 Mar 2025 2,490 32,888 - 0.8 1,917 Common Stock
Matthew Winton COO Grant, award, or other acquisition of securities at price $ 0.77 per share. 31 Mar 2025 2,490 7,388 - 0.8 1,917 Common Stock
Douglas A. Treco Director, CEO 11 Mar 2025 400,000 400,000 - - Stock Option (right to buy)
Douglas A. Treco Director, CEO 11 Mar 2025 100,000 100,000 - - Restricted Stock Units
Sanjay Subramanian SVP, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2025 145,000 145,000 - - Stock Option (right to buy)
Sanjay Subramanian SVP, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2025 38,500 38,500 - - Restricted Stock Units
Matthew Winton COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2025 145,000 145,000 - - Stock Option (right to buy)
Matthew Winton COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2025 41,500 41,500 - - Restricted Stock Units
Douglas A. Treco Director, CEO 30 Sep 2024 1,710 22,375 - 4.5 7,610 Common Stock
Matthew Winton COO Grant, award, or other acquisition of securities at price $ 4.45 per share. 30 Sep 2024 1,710 4,898 - 4.5 7,610 Common Stock
Edward T. Mathers Director 18 Jun 2024 28,000 28,000 - - Stock Option (right to buy)
Martin William Edwards Director 18 Jun 2024 28,000 28,000 - - Stock Option (right to buy)
Robert Hopfner Director 18 Jun 2024 28,000 28,000 - - Stock Option (right to buy)
Axel Bolte Director 18 Jun 2024 28,000 28,000 - - Stock Option (right to buy)
Lynne Sullivan Director 18 Jun 2024 28,000 28,000 - - Stock Option (right to buy)
Sarah Bhagat Director 18 Jun 2024 28,000 28,000 - - Stock Option (right to buy)
Douglas A. Treco Director, CEO 01 Apr 2024 25,000 28,188 - - Common Stock
Douglas A. Treco Director, CEO 01 Apr 2024 7,523 20,665 - 6.9 52,210 Common Stock
Douglas A. Treco Director, CEO 01 Apr 2024 25,000 75,000 - - Restricted Stock Units
Matthew Winton COO Grant, award, or other acquisition of securities at price $ 3.33 per share. 28 Mar 2024 3,188 3,188 - 3.3 10,616 Common Stock
Douglas A. Treco Director, CEO 13 Mar 2024 300,000 300,000 - - Stock Option (right to buy)
Sanjay Subramanian SVP, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Mar 2024 165,000 165,000 - - Stock Option (right to buy)
Matthew Winton COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Mar 2024 175,000 175,000 - - Stock Option (right to buy)
Robert Hopfner Director 01 Aug 2023 714,285 1,571,741 - 4.8 3,428,568 Common Stock
Robert Hopfner Director 01 Aug 2023 119,048 2,923,110 - 4.8 571,430 Common Stock
Edward T. Mathers Director 13 Jun 2023 16,000 16,000 - - Stock Option (right to buy)
Martin William Edwards Director 13 Jun 2023 16,000 16,000 - - Stock Option (right to buy)
Robert Hopfner Director 13 Jun 2023 16,000 16,000 - - Stock Option (right to buy)
Axel Bolte Director 13 Jun 2023 16,000 16,000 - - Stock Option (right to buy)
Lynne Sullivan Director 13 Jun 2023 16,000 16,000 - - Stock Option (right to buy)
Sarah Bhagat Director 13 Jun 2023 16,000 16,000 - - Stock Option (right to buy)
Robert Hopfner Director 11 May 2023 219,230 3,432,816 - 6.5 1,420,610 Common Stock
Robert Hopfner Director 11 May 2023 228,702 3,661,518 - 6.3 1,429,388 Common Stock
Axel Bolte Director 01 May 2023 100,000 100,000 - - Stock option (right to buy)
Matthew Winton COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2023 250,000 250,000 - - Stock option (right to buy)
Douglas A. Treco Director, CEO 01 Apr 2023 100,000 100,000 - - Restricted stock units
Douglas A. Treco Director, CEO 01 Apr 2023 800,000 800,000 - - Stock option (right to buy)
Axel Bolte Director 31 Mar 2023 4,806 266,696 - 2.2 10,621 Common Stock
Sanjay Subramanian SVP, CFO Grant, award, or other acquisition of securities at price $ 2.21 per share. 31 Mar 2023 979 28,079 - 2.2 2,164 Common Stock
Robert Hopfner Director 29 Mar 2023 344,592 3,213,586 - 4.5 1,563,724 Common Stock
Robert Hopfner Director 27 Mar 2023 156,766 2,868,994 - 4.2 652,335 Common Stock
Robert Hopfner Director 27 Mar 2023 51,074 2,712,228 - 3.7 188,729 Common Stock
Sanjay Subramanian SVP, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2023 135,000 135,000 - - Stock option (right to buy)
Henric Bjorn Bjarke SVP, COO Purchase of securities on an exchange or from another person at price $ 1.39 per share. 15 Dec 2022 21,500 105,441 - 1.4 29,885 Common Stock
Axel Bolte Director, Chief Executive Officer 30 Sep 2022 3,315 261,890 - 2.3 7,558 Common Stock
Henric Bjorn Bjarke SVP, COO Grant, award, or other acquisition of securities at price $ 2.28 per share. 30 Sep 2022 3,315 83,941 - 2.3 7,558 Common Stock
Edward T. Mathers Director 10 Jun 2022 9,367 9,367 - - Stock Option (right to buy)
Martin William Edwards Director 10 Jun 2022 9,367 9,367 - - Stock Option (right to buy)
Robert Hopfner Director 10 Jun 2022 9,367 9,367 - - Stock Option (Right to Buy)
Douglas A. Treco Director 10 Jun 2022 9,367 9,367 - - Stock Option (right to buy)
Lynne Sullivan Director 10 Jun 2022 9,367 9,367 - - Stock Option (right to buy)
Sarah Bhagat Director 10 Jun 2022 9,367 9,367 - - Stock Option (right to buy)
Robert Hopfner Director 19 Apr 2022 1,070,000 2,661,154 - 3.7 3,948,300 Common Stock
Axel Bolte Director, Chief Executive Officer 19 Apr 2022 67,750 258,575 - 3.7 249,998 Common Stock
Henric Bjorn Bjarke SVP, COO Purchase of securities on an exchange or from another person at price $ 3.69 per share. 19 Apr 2022 27,100 80,626 - 3.7 99,999 Common Stock
Sanjay Subramanian SVP, CFO Purchase of securities on an exchange or from another person at price $ 3.69 per share. 19 Apr 2022 27,100 27,100 - 3.7 99,999 Common Stock
Sanjay Subramanian SVP, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2022 180,000 180,000 - - Stock option (right to buy)
Axel Bolte Director, Chief Executive Officer 24 Feb 2022 275,000 275,000 - - Stock option (right to buy)
Henric Bjorn Bjarke SVP, COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2022 115,000 115,000 - - Stock option (right to buy)
Axel Bolte Director, Chief Executive Officer 24 Jun 2021 66,788 257,613 - 1.0 65,452 Common Stock
Axel Bolte Director, Chief Executive Officer 24 Jun 2021 66,788 100,480 - - Stock Option (right to buy)
Axel Bolte Director, Chief Executive Officer 24 Jun 2021 66,788 190,825 - 0.0 7 Common Stock
Edward T. Mathers Director 23 Jun 2021 9,367 9,367 - - Stock Option (right to buy)
Martin William Edwards Director 23 Jun 2021 9,367 9,367 - - Stock Option (right to buy)
Robert Hopfner Director 23 Jun 2021 9,367 9,367 - - Stock Option (right to buy)
Douglas A. Treco Director 23 Jun 2021 9,367 9,367 - - Stock Option (right to buy)
Lynne Sullivan Director 23 Jun 2021 9,367 9,367 - - Stock Option (right to buy)
Sarah Bhagat Director 23 Jun 2021 9,367 9,367 - - Stock Option (right to buy)
Stephen J. DiPalma Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2021 15,000 15,000 - - Stock option (Right to Buy)
Stephen Basso SVP Finance (PFO) Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2021 13,000 13,000 - - Stock Option (right to buy)
Axel Bolte Director, Chief Executive Officer 04 Mar 2021 117,000 117,000 - - Stock option (right to buy)
Steven Jungles SVP, CTO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2021 42,000 42,000 - - Stock Option (right to buy)
Henric Bjorn Bjarke SVP, COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2021 51,000 51,000 - - Stock option (right to buy)
Stephen Basso SVP Finance (PFO) Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2021 27,000 27,000 - - Stock Option (right to buy)
Deborah Wenkert SVP, CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2021 100,000 100,000 - - Stock option (Right to Buy)
Pedro Huertas SVP, CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 36,074 36,074 - - Stock Option (Right to buy)
Axel Bolte Director, Chief Executive Officer 13 Jan 2021 66,788 66,788 - - Stock option (right to buy)
Axel Bolte Director, Chief Executive Officer 13 Jan 2021 159,187 159,187 - - Stock Option (right to buy)
Steven Jungles SVP, CTO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 44,315 44,315 - - Stock Option (right to buy)
Henric Bjorn Bjarke SVP, COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 51,105 51,105 - - Stock Option (right to buy)
Stephen Basso SVP Finance (PFO) Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 41,794 41,794 - - Stock Option (right to buy)
Robert Hopfner Director, Ten Percent Owner 28 Jul 2020 10,489,510 0 - - Series A-2 Convertible Preferred Stock
Robert Hopfner Director, Ten Percent Owner 28 Jul 2020 1,403,654 1,403,654 - - Common Stock
Robert Hopfner Director, Ten Percent Owner 28 Jul 2020 187,500 1,591,154 - 16 3,000,000 Common Stock
Steven Jungles See Remarks 28 Jul 2020 13,381 55,417 - - Common Stock
Steven Jungles See Remarks 28 Jul 2020 100,000 0 - - Series A Convertible Preferred Stock
Joseph Schlessinger Ten Percent Owner 28 Jul 2020 13,381 286,479 - - Common Stock
Joseph Schlessinger Ten Percent Owner 28 Jul 2020 100,000 0 - - Series A Convertible Preferred Stock
Edward T. Mathers None 23 Jul 2020 9,367 9,367 - - Stock Option (right to buy)
Pedro Huertas See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2020 43,951 43,951 - - Stock Option (right to buy)
Martin William Edwards None 23 Jul 2020 9,367 9,367 - - Stock Option (right to buy)
Robert Hopfner None 23 Jul 2020 9,367 9,367 - - Stock Option (right to buy)
Axel Bolte Director, See Remarks, Ten Percent Owner 23 Jul 2020 287,706 287,706 - - Stock Option (right to buy)
Henric Bjorn Bjarke See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2020 32,905 32,905 - - Stock Option (right to buy)
Douglas A. Treco None 23 Jul 2020 9,367 9,367 - - Stock Option (right to buy)
Lynne Sullivan None 23 Jul 2020 9,367 9,367 - - Stock Option (right to buy)
Stephen Basso Senior Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2020 27,433 27,433 - - Stock Option (right to buy)
Sarah Bhagat None 23 Jul 2020 9,367 9,367 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters